Attention: Information on this site is provided for informational purposes and is not meant to substitute for the advice provided by your own physician or other medical professional. You should not use the information contained herein for treating a health problem or disease, or prescribing any medication. iDrugs24.com is not responsible for any damage to your health as the result of self treatment.
# On 2024-May-23 aproximate price on "ESSENTIALE FORTE CPS 300MG N30" in Riga city, Latvia is:
8.24€ 8.92$ 7.02£ 952Rub 95.9SEK 35PLN 32.84₪
Maximum allowed state defined price ( from ZVA webpage) Euro:
* This table was compiled fully automatically, independently from any advertisers, transparently and without any modification relaying the open offers available on the mentioned dates.
.
ESSENTIALE FORTE N 300MG N30
Package leaflet: Information for the user
Essentiale forte N 300 mg hard capsules
Soybean phospholipids
Read all of this leaflet carefully before you start using this medicine because it contains important information for you.
Always take this medicine exactly as described in this leaflet or as your doctor or pharmacist has told you. - Keep this leaflet. You may need to read it again. - Ask your pharmacist if you need more information or advice. - If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. See section 4. - You must talk to a doctor if you do not feel better or if you feel worse after a while.
What is in this leaflet:
1. What Essentiale forte N is and what it is used for 2. What you need to know before you use Essentiale forte N 3. How to use Essentiale forte N 4. Possible side effects 5 How to store Essentiale forte N 6. Contents of the pack and other information
1. What Essentiale forte N is and what it is used for
Essentiale forte N is an herbal preparation for the supportive care of liver diseases. Essentiale forte N capsules are used as a means of supportive care in case of chronic hepatitis and toxic nutritional liver damage (e.g. damage caused by alcohol, etc.). This medicine is not a substitute for the need to avoid substances harmful to the liver (e.g. alcohol). In case of chronic hepatitis, supportive care using soybean phospholipids is only indicated if it improves your subjective sense of well-being. You must talk to a doctor if your symptoms worsen or you develop other unclear complaints.
2. What you need to know before you use Essentiale forte N Do not use Essentiale forte N
- if you are allergic to soybeans, phosphatidylcholine, soy protein, nuts or any of the other ingredients of this medicine (listed in section 6).
Warnings and precautions
Talk to your doctor, pharmacist or nurse before taking Essentiale forte N. - this medicine is not a substitute for avoiding substances that cause liver damage (e.g. alcohol) - supportive treatment of chronic hepatitis with soybean phospholipids is only indicated if it improves the patient’s subjective sense of well-being. - you must talk to your doctor if the symptoms worsen or you get any other vague complaints
Children and adolescents
Children should not use Essentiale forte N due to insufficient data.
Other medicines and Essentiale forte N
Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines. Interaction of Essentiale forte N with anticoagulants (medicines which reduce blood clotting) cannot be excluded. It may therefore be necessary to adjust the dosage of the anticoagulant. Talk to your doctor if you are taking Essentiale forte N concomitantly with anticoagulants.
Pregnancy, breast-feeding and fertility
If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine. Products made from soybeans are widely used in human food and to date, no facts have been uncovered indicating hazard during pregnancy. However, research data are insufficient. Hence, the use of Essentiale forte N capsule is not recommended during pregnancy and breast-feeding.
Driving and using machines
Essentiale forte N capsules have no effect on the ability to drive or use machines.
Essentiale forte N contains ethanol
Essentiale forte N contains a small amount of ethanol (8.1 mg per hard capsule).
Essentiale forte N contains soybean oil
Essentiale forte N contains refined soybean oil. Do not use this medicine if you are allergic to soy.
Essentiale forte N contains hydrogenatedcastor oil
Essentiale forte N contains hydrogenated castor oil, which can cause gastric problems, diarrhoea and skin reactions.
3. How to use Essentiale forte N
Always use Essentiale forte N as your doctor or pharmacist. has told you Check with your doctor, pharmacist or nurse if you are not sure. The hard capsules are taken during a meal without chewing and with a sufficient quantity of liquid. Duration of treatment depends on the course of the illness. Take 2 hard capsules (total of 600 mg of soybean phospholipids) 3 times per day. Do not take more than 6 hard capsules per day (total of 1,800 mg soybean phospholipids).
Use in children
Children should not use Essentiale forte N due to insufficient data. If you feel that the effect of Essentiale forte N is too strong or too weak, talk to your doctor or pharmacist.
If you take more Essentiale forte N than you should
No symptoms of toxicity have been reported in case of an overdose of Essentiale forte N. An overdose can exacerbate side effects.
If you forget to take Essentiale forte N
Do not take a double dose to make up for a forgotten dose. If you have any further questions on the use of this medicine, ask your doctor, pharmacist or nurse.
4. Possible side effects
Like all medicines, Essentiale forte N can cause side effects, although not everybody gets them. The following classification based on frequency is used when evaluating side effects: - very common (> 1/10); - common (> 1/100 to > 1/10); - uncommon (> 1/1,000 to > 1/100) - rare (> 1/10,000 to >1/1,000) - very rare (< 1/10,000) - unknown (cannot be estimated from available data). Digestive tract disorders Unknown: stomach complaints, soft stools or diarrhoea. Skin and subcutaneous tissue disorders Unknown: allergic reaction, e.g. exanthema, rash and urticaria; pruritus.
Reporting of side effects
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly viawww.ravimiamet.ee/en. By reporting side effects you can help provide more information on the safety of this medicine.
5. How to store Essentiale forte N
Keep this medicine out of the sight and reach of children. Do not store at a temperature higher than 25 °C. Store in the original package in order to protect from moisture. Do not use this medicine after the expiry date which is stated on the carton. The expiry date refers to the last day of that month. Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.
6. Contents of the pack and other information What Essentiale forte N contains
- The active ingredient is soybean phospholipids. One hard capsule contains 300 mg of essential soybean phospholipids, including 76% of (3-sn-phosphatidyl)-choline. - The excipients are Capsule contents: solid fat, refined soybean oil, alpha tocopherol, hydrogenated castor oil, ethanol 96%, ethyl vanillin, 4-methoxyacetophenone Capsule body: gelatine, purified water, titanium dioxide (E171), yellow iron oxide (E172), black iron oxide (E172), red iron oxide (E172), sodium lauryl sulphate.
What Essentiale forte N looks like and contents of the pack
Oblong, opaque, khaki coloured hard capsules. The capsule contains a honey-like paste. The hard capsules are packaged in a blister pack. The pack contains 30 or 100 hard capsules. Not all pack sizes may be marketed.
Marketing Authorisation Holder and Manufacturer
Marketing Authorisation Holder
sanofi-aventis Estonia OÜ Pärnu mnt. 139 E/2 11317 Tallinn Estonia
Manufacturer
Nattermann & Cie GmbH Nattermannallee 1 50829 Cologne Germany For any information about this medicine, please contact the Marketing Authorisation Holder. sanofi-aventis Estonia OÜ Pämu mnt. 139 E/2 11317 Tallinn Phone: +372 627 3488
This leaflet was last revised in December 2017 Other sources of information
Detailed information about this medicine is available on the website of the State Agency of Medicines: www.ravimiamet.ee/en